Victory Capital Management
AUPH icon

Victory Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Victory Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-97,662
Closed -$734K – 2597
2022
Q3 		$734K Hold
97,662
– – ﹤0.01% 1869
2022
Q2 		$982K Sell
97,662
-7,929
-8% -$88.6K ﹤0.01% 1756
2022
Q1 		$1.09M Buy
105,591
+480
+0.5% +$7.42K ﹤0.01% 1765
2021
Q4 		$2.4M Sell
105,111
-8,825
-8% -$209K ﹤0.01% 1502
2021
Q3 		$2.52M Hold
113,936
– – ﹤0.01% 1526
2021
Q2 		$1.48M Sell
113,936
-5,734
-5% -$73K ﹤0.01% 1729
2021
Q1 		$1.55M Sell
119,670
-6,250
-5% -$90.7K ﹤0.01% 1720
2020
Q4 		$1.74M Sell
125,920
-9,077
-7% -$132K ﹤0.01% 1565
2020
Q3 		$1.99M Sell
134,997
-57,856
-30% -$838K ﹤0.01% 1448
2020
Q2 		$3.13M Sell
192,853
-192,853
-50% -$3.09M ﹤0.01% 1295
2020
Q1 		$5.6M Buy
385,706
+113,408
+42% +$2M ﹤0.01% 1241
2019
Q4 		$5.52M Hold
272,298
– – 0.01% 1158
2019
Q3 		$1.45M Buy
272,298
+265,394
+3,844% +$1.61M ﹤0.01% 1586
2019
Q2 		$45K Hold
6,904
– – ﹤0.01% 1748
2019
Q1 		$45K Buy
+6,904
New +$45.8K ﹤0.01% 1715

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Victory Capital Management's AUPH Position: Q4 2022 in Review

Victory Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 97,662 shares — an estimated $734K sold.

Victory Capital Management first reported a position in AUPH in Q1 2019 and held it in 15 quarters. The position peaked at $5.6M in Q1 2020. 192 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • Victory Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 97,662 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $734K.
  • Victory Capital Management first reported a position in Aurinia Pharmaceuticals in Q1 2019 and held it in 15 quarters.
  • Victory Capital Management's Aurinia Pharmaceuticals position peaked at $5.6M in Q1 2020.
  • 192 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.